Virtus Health Osake

Virtus Health P/B

Delisted

P/B (Hinta-kirjanpitoarvo-suhde) yhtiöstä Virtus Health (VRT.AX) 15.8.2026 päivämäärällä on 2,36. Edellisenä vuonna P/B (Hinta-kirjanpitoarvo-suhde) oli 2,64 — muutos −10,59 % (matalampi).

P/B

2,36

YoY

−10,59%

Viimeksi päivitetty:

P/B (Hinta-kirjanpitoarvo-suhde) yhtiöstä Virtus Health on 2026 2,36 . P/B (Hinta-kirjanpitoarvo-suhde) yhtiöstä Virtus Health oli 2025 2,64 . Se laskee −10,59% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Virtus Health Osakeanalyysi

Mitä Virtus Health tekee? Virtus Health Ltd is a company in the field of assisted reproduction and fertility, based in Sydney, Australia. Founded in 2007, the company is a leader in the development and application of innovative technologies and methods to help couples worldwide to become pregnant. The business model of Virtus Health includes the provision of IVF treatments (In-vitro Fertilization), IUI treatments (Intrauterine Insemination), egg donations, and other methods for successful fertilization of eggs and sperm cells. It is a highly specialized field that requires expertise and specialized skills. The company owns and operates a number of specialized fertility clinics in Australia, Ireland, Denmark, Singapore, and the United Arab Emirates. These clinics offer patients all services related to assisted reproduction, including specialist consultation and advice, treatment planning, medical treatments, surgical interventions, medication administration, and aftercare. As part of its business model, Virtus Health also operates a variety of laboratories where embryos are cultured and genetic and prenatal diagnostic procedures are performed. The company continuously invests in research and development, the development of new technologies, and the exploration of new markets in this field. Virtus Health is constantly seeking new ways to improve pregnancy rates for its patients. The company is divided into different divisions, each offering different services for assisted reproduction. For example, Virtus Health operates the brand "IVFAustralia," the leading Australian clinic for assisted reproduction, where patients receive the best possible medical care for all questions regarding fertilization technologies. Virtus Health is also diversified and offers various services in the field of assisted reproduction. For example, it operates the "California Cryobank," one of the world's largest sperm banks specializing in the storage and provision of sperm cells for assisted fertilization. Other product lines of the company include "OTIC Americas," a laboratory firm for medical devices, and "AAB College," an educational institute for medical personnel in Kosovo. An important aspect of Virtus Health's business model is its close collaboration with other companies in the industry. This allows for better support for both patients and the market as a whole. Over the years, the company has formed partnerships with other medical institutions. Overall, Virtus Health is a leading provider of services in the field of assisted reproduction and fertility. It is a specialized company that offers a variety of services to help couples expand their families. Virtus Health is a good example of a company that prioritizes the needs of its customers through innovation, efficiency, and high-quality services. Virtus Health on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Virtus Health osakkeesta

Yhtiön Virtus Health P/B (Hinta-kirjanpitoarvo-suhde) on 2,36 vuonna 2026.

P/B (Hinta-kirjanpitoarvo-suhde) yhtiöstä Virtus Health muuttui arvosta 2,64 arvoon 2,36, mikä edustaa −10,59 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää P/B (Hinta-kirjanpitoarvo-suhde) Virtus Health:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Hinta-kirjanpitoarvo-suhde vertaa yhtiön markkina-arvoa sen kirjanpitoarvoon. Matala P/B voi viitata aliarvostettuun osakkeeseen, kun taas korkea P/B voi osoittaa yliarvostusta tai vahvoja kasvuodotuksia.

P/B = Osakekurssi / Kirjanpitoarvo per osake

Arvioidakseen P/B (Hinta-kirjanpitoarvo-suhde):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja P/B (Hinta-kirjanpitoarvo-suhde):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata P/B (Hinta-kirjanpitoarvo-suhde):n Virtus Health alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Virtus Health

Kaikki tunnusluvut — Virtus Health